{"title":"Exploring the complex immunomodulatory effects and gut defense via oral administration of Astragali radix water extract to normal mice.","authors":"Mi-Gi Lee, Youngju Song, Hee Kang","doi":"10.1186/s12906-024-04667-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Astragali radix (AR) is one of the most widely used traditional Chinese herbal medicines. It exhibits diverse biological activities, including immunomodulatory and anti-inflammatory properties; however, some of its activities have only been demonstrated in vitro.</p><p><strong>Objective: </strong>To examine the effects of orally administered AR extract on immune cells and the intestine under physiological conditions, which bridges the gap between previously observed in vitro outcomes and in vivo results.</p><p><strong>Methods: </strong>AR extract was prepared by hot water extraction. Three separate animal experiments were conducted to isolate macrophages, splenocytes, and the small intestine epithelium. For the macrophage preparation experiment, an intraperitoneal injection of sterile thioglycolate was administered. The mice received oral AR extract at doses of 0.1, 0.5, or 2.5 g/kg for ten days. At the end of each experiment, cells or tissues were isolated. A portion of macrophages and splenocytes were analyzed for the phenotypic changes. The remaining cells were cultured and stimulated with lipopolysaccharide (LPS) or mitogen ex vivo to assess activation status, proliferation, and cytokine production. Samples of the intestine were subjected to real-time RT-PCR.</p><p><strong>Results: </strong>Peritoneal macrophages from AR-treated mice exhibited increased expression of scavenger receptors, including SRA and CD36. Stimulation of these macrophages ex vivo with LPS selectively modulated the inflammatory response, including reduced expression of the costimulatory molecules CD40 and CD86, which are important for T cell responses, without affecting TNF-α and IL-6 production. Splenocytes from AR-treated mice exhibited a dose-dependent increase in CD4 and CD8 T cells; however, stimulation with mitogen decreased T cell proliferation and reduced IFN-γ production, which is essential for macrophage activation. An analysis of the small intestinal epithelium revealed an attenuated antimicrobial response, including reduced IgA content in the lumen and decreased expression of mucin-2 and polymeric Ig receptor genes.</p><p><strong>Conclusion: </strong>The response of immune cells following oral treatment with AR extract did not replicate the previously documented in vitro findings. Immune cells and intestinal epithelium from mice administered oral AR extract exhibited a selective anti-inflammatory phenotype. The overall findings indicate that the systemic effects after oral administration of AR extract include reduced sensitivity to inflammatory insults.</p>","PeriodicalId":9128,"journal":{"name":"BMC Complementary Medicine and Therapies","volume":"24 1","pages":"361"},"PeriodicalIF":3.3000,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460088/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Complementary Medicine and Therapies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12906-024-04667-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Astragali radix (AR) is one of the most widely used traditional Chinese herbal medicines. It exhibits diverse biological activities, including immunomodulatory and anti-inflammatory properties; however, some of its activities have only been demonstrated in vitro.
Objective: To examine the effects of orally administered AR extract on immune cells and the intestine under physiological conditions, which bridges the gap between previously observed in vitro outcomes and in vivo results.
Methods: AR extract was prepared by hot water extraction. Three separate animal experiments were conducted to isolate macrophages, splenocytes, and the small intestine epithelium. For the macrophage preparation experiment, an intraperitoneal injection of sterile thioglycolate was administered. The mice received oral AR extract at doses of 0.1, 0.5, or 2.5 g/kg for ten days. At the end of each experiment, cells or tissues were isolated. A portion of macrophages and splenocytes were analyzed for the phenotypic changes. The remaining cells were cultured and stimulated with lipopolysaccharide (LPS) or mitogen ex vivo to assess activation status, proliferation, and cytokine production. Samples of the intestine were subjected to real-time RT-PCR.
Results: Peritoneal macrophages from AR-treated mice exhibited increased expression of scavenger receptors, including SRA and CD36. Stimulation of these macrophages ex vivo with LPS selectively modulated the inflammatory response, including reduced expression of the costimulatory molecules CD40 and CD86, which are important for T cell responses, without affecting TNF-α and IL-6 production. Splenocytes from AR-treated mice exhibited a dose-dependent increase in CD4 and CD8 T cells; however, stimulation with mitogen decreased T cell proliferation and reduced IFN-γ production, which is essential for macrophage activation. An analysis of the small intestinal epithelium revealed an attenuated antimicrobial response, including reduced IgA content in the lumen and decreased expression of mucin-2 and polymeric Ig receptor genes.
Conclusion: The response of immune cells following oral treatment with AR extract did not replicate the previously documented in vitro findings. Immune cells and intestinal epithelium from mice administered oral AR extract exhibited a selective anti-inflammatory phenotype. The overall findings indicate that the systemic effects after oral administration of AR extract include reduced sensitivity to inflammatory insults.
背景:黄芪(AR)是应用最广泛的传统中药材之一。它具有多种生物活性,包括免疫调节和抗炎特性;然而,其中一些活性仅在体外得到证实:目的:研究在生理条件下口服 AR 提取物对免疫细胞和肠道的影响,从而缩小之前观察到的体外结果与体内结果之间的差距:方法:用热水提取法制备 AR 提取物。方法:采用热水提取法制备 AR 提取物,并分别进行了三项动物实验,以分离巨噬细胞、脾细胞和小肠上皮细胞。在巨噬细胞制备实验中,腹腔注射无菌巯基乙酸盐。小鼠口服 AR 提取物,剂量为 0.1、0.5 或 2.5 克/千克,共十天。每次实验结束后,分离细胞或组织。对部分巨噬细胞和脾细胞的表型变化进行分析。对其余细胞进行培养,并用脂多糖(LPS)或有丝分裂原进行体外刺激,以评估活化状态、增殖和细胞因子的产生。对肠道样本进行实时 RT-PCR:结果:经 AR 处理的小鼠腹腔巨噬细胞的清道夫受体(包括 SRA 和 CD36)表达量增加。用 LPS 在体外刺激这些巨噬细胞可选择性地调节炎症反应,包括降低对 T 细胞反应很重要的成本刺激分子 CD40 和 CD86 的表达,但不影响 TNF-α 和 IL-6 的产生。经 AR 处理的小鼠脾细胞中 CD4 和 CD8 T 细胞的增加呈剂量依赖性;然而,有丝分裂原的刺激会降低 T 细胞的增殖并减少 IFN-γ 的产生,而 IFN-γ 是巨噬细胞活化的必要条件。对小肠上皮细胞的分析表明,抗微生物反应减弱,包括肠腔中的 IgA 含量降低,粘蛋白-2 和聚合 Ig 受体基因的表达减少:结论:口服 AR 提取物后免疫细胞的反应并没有重复之前体外实验的结果。口服 AR 提取物的小鼠的免疫细胞和肠上皮细胞表现出选择性抗炎表型。总体研究结果表明,口服 AR 提取物后的全身效应包括降低对炎症损伤的敏感性。